PLAIN ENGLISH DESIGN LIMITED

Comprehensive Financial Health Assessment: Plain English Design Limited

1. Financial Health Score: C+

Explanation: The patient is fundamentally alive and active but is currently suffering from acute short-term breathlessness (liquidity constraints) and a dangerous drop in blood pressure (profitability). While the company possesses a strong skeletal structure (valuable fixed assets) and a healthy heartbeat (growing turnover), the massive drop in net margins and a persistent working capital deficit mean it is living somewhat paycheck-to-paycheck. The recent injection of a £508k loan acts as a necessary blood transfusion, but the underlying business must address its margin compression to ensure long-term survival and health.

2. Key Vital Signs

• Heartbeat (Turnover): Strong & Steady. Revenue increased from £7.26M to £8.24M (a 13.5% increase). The top-line pulse is robust, indicating strong market demand for the company's design and manufacturing services.
• Blood Pressure (Profitability): Dangerously Low. Operating profit collapsed from £261,150 to just £84,624. Net profit margin fell from a reasonable 2.8% to a critically thin 0.6%. The gross profit margin also contracted from 47% to 43%, meaning the cost of sales is rising faster than revenue.
• Oxygen Levels (Liquidity): Gasping for Air. Current liabilities (£3.68M) drastically exceed current assets (£2.34M), resulting in net current liabilities of £1.35M. The current ratio is roughly 0.63:1, meaning the company has only 63p of short-term assets for every £1 of short-term debt. Without cash flow or external support, the patient cannot comfortably meet its immediate obligations.
• Hydration (Cash Reserves): Slightly Dehydrated. Cash at bank fell from £643k to £568k. While still positive, this drop—combined with the net current liabilities—shows cash is being consumed faster than it is being generated from operations.
• Bone Density (Capital Structure): Heavy but Illiquid. Net assets stand at £1.75M, supported heavily by £3.78M in tangible fixed assets (likely property, plant, and equipment). However, wealth tied up in bricks and machinery cannot easily be used to pay staff or suppliers.

3. Diagnosis

Primary Condition: Acute Margin Compression with Chronic Working Capital Deficiency

The financial data reveals a business that is growing on the outside but shrinking on the inside. The 13.5% increase in turnover is encouraging, but the diagnosis turns concerning when we look at what happens to that revenue. The gross margin dropped by 4%, indicating that the cost of manufacturing and materials is swallowing a larger portion of income. Furthermore, administrative and distribution expenses have increased significantly, eating away the remaining gross profit and leaving an anemic net margin of just 0.6%.

The most severe symptom of distress is the working capital deficit (net current liabilities of £1.35M). In medical terms, the company is experiencing a severe liquidity blockage. It owes a substantial amount to creditors within the year, but its current assets (stock, debtors, and cash) are insufficient to cover these short-term debts.

The company is surviving through the support of long-term assets and likely relying on the steady rhythm of its cash cycle to keep the lights on. However, paying out £196,000 in dividends during a year when profit fell so sharply is akin to drawing blood from an already anemic patient—it weakens the balance sheet further.

Mitigating Factor (The Blood Transfusion): The post-balance-sheet event is critical. In June 2018, the company secured an additional £508,832 in loan funding from Barclays Bank to finance a New York showroom. This injection improves the immediate cash position, but it also adds to the long-term debt burden, meaning the company must service higher interest payments going forward.

4. Recommendations

To restore this patient to full financial health, the following immediate and long-term treatments are prescribed:

1. Emergency Triage (Working Capital Management): The £1.35M working capital deficit must be addressed. Negotiate longer payment terms with suppliers where possible, and aggressively chase outstanding debtors (£835k) to convert them into cash. Avoid taking on further short-term debt.
2. Surgical Cost Review (Margin Restoration): The drop from a 47% to 43% gross margin, combined with rising admin costs, requires immediate surgical intervention. Conduct a granular review of the cost of sales. Are material costs rising? Is manufacturing efficiency dropping? Identify the root cause of the margin bleed and apply pressure to stop it.
3. Dividend Restraint (Preserve Cash): While the directors have a right to dividends, distributing £196k during a period of shrinking profits and a working capital deficit is unsustainable. Future dividends should be restricted until net current assets turn positive and the margin recovers.
4. Monitor the New York Expansion Carefully: The Barclays loan provides a helpful cash buffer, but expanding to New York will likely incur further operating losses before it turns profitable. Set strict Key Performance Indicators (KPIs) and cash burn limits for the US operation. If the new showroom begins to hemorrhage cash, be prepared to intervene quickly to protect the core UK business.